Exane Derivatives

SEC CIK: 0001623883
Latest filing: Jul 12, 2022

SEC filings (opens in a new tab)

IDXX holding history

IDEXX Laboratories Inc in every 13F filed by Exane Derivatives, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IDXX overview All 13F holders of IDXX Full Q2 2022 holdings

Shares (Q1 2022): 0; Sold out in Q1 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 1; Since Q4 2021

Holdings of IDXX by Exane Derivatives, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2022	0	$0	0.0%	−61−100.0%	Sold out	Holders
Q4 2021	61	$40.2K	<0.1%	+61	New	Holders